Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lubka T Roumenina

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Blood|August 15, 2015
C3dg-CR3 interaction in erythrophagocytosisLubka T Roumenina
Blood|January 28, 2021
Terminal complement without C5 convertase?Lubka T Roumenina
Kidney International|September 24, 2021
Complement factor H: a guardian within?Idris Boudhabhay, Lubka T Roumenina
Methods in Molecular Biology (Clifton, N.J.)|April 13, 2021
The Benefits of Complement Measurements for the Clinical PracticeAnne Grunenwald, Lubka T Roumenina
Nature Cancer|October 21, 2022
COMPLEMENTing immunotherapyLubka T Roumenina, Isabelle Cremer
Biological Chemistry|October 18, 2022
Assessment of the breadth of binding promiscuity of heme towards human proteinsLubka T Roumenina, Jordan D Dimitrov
Blood|September 30, 2021
Heme: driver of erythrocyte eliminationJordan D Dimitrov, Lubka T Roumenina
Blood|December 12, 2024
Polyreactive IgM: a trigger for aHUSLubka T Roumenina, Jordan D Dimitrov
European Journal of Immunology|July 12, 2024
The complement system as a target in cancer immunotherapyNicolas S Merle, Lubka T Roumenina
Nature Reviews. Clinical Oncology|May 7, 2020
B cells and complement at the forefront of chemotherapyCatherine Sautès-Fridman, Lubka T Roumenina
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Blood|August 15, 2015
C3dg-CR3 interaction in erythrophagocytosisLubka T Roumenina
Blood|January 28, 2021
Terminal complement without C5 convertase?Lubka T Roumenina
Kidney International|September 24, 2021
Complement factor H: a guardian within?Idris Boudhabhay, Lubka T Roumenina
Methods in Molecular Biology (Clifton, N.J.)|April 13, 2021
The Benefits of Complement Measurements for the Clinical PracticeAnne Grunenwald, Lubka T Roumenina
Nature Cancer|October 21, 2022
COMPLEMENTing immunotherapyLubka T Roumenina, Isabelle Cremer
Biological Chemistry|October 18, 2022
Assessment of the breadth of binding promiscuity of heme towards human proteinsLubka T Roumenina, Jordan D Dimitrov
Blood|September 30, 2021
Heme: driver of erythrocyte eliminationJordan D Dimitrov, Lubka T Roumenina
Blood|December 12, 2024
Polyreactive IgM: a trigger for aHUSLubka T Roumenina, Jordan D Dimitrov
European Journal of Immunology|July 12, 2024
The complement system as a target in cancer immunotherapyNicolas S Merle, Lubka T Roumenina
Nature Reviews. Clinical Oncology|May 7, 2020
B cells and complement at the forefront of chemotherapyCatherine Sautès-Fridman, Lubka T Roumenina
Pageof 13